Segui
Egesta Lopci, MD, PhD
Egesta Lopci, MD, PhD
Nuclear Medicine, IRCCS Humanitas Research Hospital
Email verificata su humanitas.it - Home page
Titolo
Citata da
Citata da
Anno
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version …
I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, ...
European journal of nuclear medicine and molecular imaging 46, 540-557, 2019
4252019
High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors
J Brummelman, EMC Mazza, G Alvisi, FS Colombo, A Grilli, J Mikulak, ...
Journal of Experimental Medicine 215 (10), 2520-2535, 2018
2922018
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence
E Lopci, I Grassi, A Chiti, C Nanni, G Cicoria, L Toschi, C Fonti, F Lodi, ...
American journal of nuclear medicine and molecular imaging 4 (4), 365, 2014
2532014
FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
N Aide, RJ Hicks, C Le Tourneau, S Lheureux, S Fanti, E Lopci
European journal of nuclear medicine and molecular imaging 46, 238-250, 2019
2152019
Diagnostic accuracy and impact on management of 18F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review
AM Maffione, E Lopci, C Bluemel, F Giammarile, K Herrmann, D Rubello
European journal of nuclear medicine and molecular imaging 42, 152-163, 2015
1602015
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery
E Lopci, L Toschi, F Grizzi, D Rahal, L Olivari, GF Castino, S Marchetti, ...
European journal of nuclear medicine and molecular imaging 43, 1954-1961, 2016
1322016
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study
A Piccardo, E Lopci, M Conte, A Garaventa, L Foppiani, V Altrinetti, ...
European journal of nuclear medicine and molecular imaging 39, 57-71, 2012
1262012
IRF4 instructs effector Treg differentiation and immune suppression in human cancer
G Alvisi, J Brummelman, S Puccio, EMC Mazza, EP Tomada, A Losurdo, ...
The Journal of clinical investigation 130 (6), 3137-3150, 2020
1242020
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC …
FE Lecouvet, DE Oprea-Lager, Y Liu, P Ost, L Bidaut, L Collette, ...
The Lancet Oncology 19 (10), e534-e545, 2018
1132018
Guidelines on nuclear medicine imaging in neuroblastoma
Z Bar-Sever, L Biassoni, B Shulkin, G Kong, MS Hofman, E Lopci, I Manea, ...
European journal of nuclear medicine and molecular imaging 45, 2009-2024, 2018
1132018
68Ga-PSMA positron emission tomography/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative multiparametric magnetic …
E Lopci, A Saita, M Lazzeri, G Lughezzani, P Colombo, NM Buffi, R Hurle, ...
The Journal of Urology 200 (1), 95-103, 2018
992018
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
E Lopci, M Riva, L Olivari, F Raneri, R Soffietti, A Piccardo, A Bizzi, ...
European journal of nuclear medicine and molecular imaging 44, 1155-1164, 2017
802017
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients
E Derenzini, MP Fina, V Stefoni, C Pellegrini, F Venturini, A Broccoli, ...
Annals of oncology 21 (6), 1173-1178, 2010
772010
Hyperprogressive disease in patients with non–small cell lung cancer treated with checkpoint inhibitors: the role of 18F-FDG PET/CT
A Castello, S Rossi, E Mazziotti, L Toschi, E Lopci
Journal of Nuclear Medicine 61 (6), 821-826, 2020
742020
The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma
N Quartuccio, G Treglia, M Salsano, MV Mattoli, B Muoio, A Piccardo, ...
Radiology and Oncology 47 (2), 97-183, 2013
722013
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR
E Lopci, A Piccardo, C Nanni, V Altrinetti, A Garaventa, A Pession, ...
Clinical nuclear medicine 37 (4), e73-e78, 2012
682012
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review
F Alongi, B De Bari, F Campostrini, S Arcangeli, DV Matei, E Lopci, ...
Critical reviews in oncology/hematology 88 (3), 550-563, 2013
672013
64CuCl2 PET/CT in prostate cancer relapse
A Piccardo, F Paparo, M Puntoni, S Righi, G Bottoni, L Bacigalupo, ...
Journal of Nuclear Medicine 59 (3), 444-451, 2018
662018
The role of 18F‐FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma
A Cistaro, E Lopci, L Gastaldo, P Fania, A Brach del Prever, F Fagioli
Pediatric Blood & Cancer, 2012
592012
Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven …
L Fournier, L Costaridou, L Bidaut, N Michoux, FE Lecouvet, ...
European radiology 31, 6001-6012, 2021
582021
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20